| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.818706 |
| P698 | PubMed publication ID | 818706 |
| P50 | author | John Najarian | Q6250133 |
| P2093 | author name string | R. L. Simmons | |
| D. E. Sutherland | |||
| M. W. Steffes | |||
| S. M. Mauer | |||
| A. J. Matas | |||
| A. Sowe | |||
| P433 | issue | 4242 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | animal disease model | Q64732998 |
| P304 | page(s) | 892-894 | |
| P577 | publication date | 1976-05-01 | |
| 1976-05-28 | |||
| P1433 | published in | Science | Q192864 |
| P1476 | title | Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats | |
| P478 | volume | 192 |
| Q38575841 | A stereotypic, transplantable liver tissue-culture system |
| Q42099658 | Administration of bone marrow derived mesenchymal stem cells into the liver: potential to rescue pseudoxanthoma elasticum in a mouse model (Abcc6-/-). |
| Q35960858 | Adult liver transplantation for metabolic liver disease |
| Q60046008 | Alcoholic liver disease: Utility of animal models |
| Q35885338 | An experimental method for rapid growth of liver in spleen. The survival and proliferation of chemically induced preneoplastic hepatocytes in spleen |
| Q77777651 | An update on high-yield hepatocyte isolation methods and on the potential clinical use of isolated liver cells |
| Q40608321 | Artificial livers--what's keeping them? |
| Q34091618 | Barriers to the successful treatment of liver disease by hepatocyte transplantation |
| Q48514110 | Basic and clinical aspects of liver growth: Prometheus revisited. Humphry Davy Rolleston Lecture 1992. |
| Q41222750 | Bilirubin glucuronidation by intact Gunn rat fibroblasts expressing bilirubin UDP-glucuronosyltransferase |
| Q47093789 | Bioengineering considerations in liver regenerative medicine. |
| Q36183426 | Cell Transplantation as Replacement Therapy for the Future |
| Q38230357 | Cell and tissue engineering for liver disease |
| Q37964633 | Cell therapies for liver diseases |
| Q34259248 | Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices |
| Q39043994 | Cellular Transplantation for Liver Diseases |
| Q33562515 | Cellular transplantation and gene therapy |
| Q41207261 | Clinical application of somatic gene therapy in inborn errors of metabolism |
| Q38820033 | Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts |
| Q72400695 | Correction of congenital indirect hyperbilirubinemia by small intestinal transplantation |
| Q30856034 | Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1. |
| Q36960927 | Degradable hydrogels derived from PEG-diacrylamide for hepatic tissue engineering |
| Q52188361 | Developmental expression of cytochrome P450 isoforms after transplantation of fetal liver tissue suspension into the spleens of adult syngenic rats. |
| Q39913424 | Differentiation and transplantation of human embryonic stem cell-derived hepatocytes |
| Q78147893 | Direct hyperplasia does not enhance the kinetics of liver repopulation in a new model of hepatocyte transplantation in the rat |
| Q72059000 | Effect of UV‐B (302 nm) irradiation on isolated rat hepatocytes |
| Q41781584 | Effects of glucose concentration in the medium on rat hepatocyte culture |
| Q36980068 | Embryonic and induced pluripotent stem cells as a model for liver disease |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q73483183 | Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats |
| Q34428708 | Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice |
| Q38567967 | Evolution of the bioartificial liver: the need for randomized clinical trials |
| Q73438218 | Experimental xenotransplantation of fresh isolated and cryopreserved pig hepatocytes: a biochemical and morphological study |
| Q37893517 | Fetal liver cell transplantation as a potential alternative to whole liver transplantation? |
| Q33897291 | Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease |
| Q34311785 | Genetic modification of xenografts |
| Q35800529 | Hepatocyte transplantation for inborn errors of metabolism |
| Q80963900 | Hepatocyte transplantation for metabolic liver disease: UK experience |
| Q39508625 | Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease |
| Q73505011 | Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells |
| Q73571715 | Hepatocyte transplantation. Advancing biology and treating children |
| Q67718479 | Hepatocyte transplantation: Back to the future |
| Q48499059 | Hepatocyte transplantation: Consider infusion before incision |
| Q36851959 | Hepatocyte transplantation: a review of laboratory techniques and clinical experiences. |
| Q77932232 | Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies |
| Q45874611 | Human hepatocyte transplantation for liver disease: current status and future perspectives. |
| Q37724582 | Human hepatocyte transplantation: current experience and future challenges. |
| Q74533049 | Improvement of the effect of hepatocyte isograft in the Gunn rat by cotransplantation of islets of Langerhans |
| Q42621309 | In vivo and ex vivo methods of growing a liver bud through tissue connection. |
| Q74506111 | Influence of different transplantation methods on liver cell survival in spleens of rats |
| Q53350792 | Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats. |
| Q45238007 | Liver transplantation and the Najarian footprint |
| Q39805144 | Magnetically Responsive Microspheres and Other Carriers for the Biophysical Targeting of Antitumor Agents |
| Q36066245 | Management of carbon tetrachloride-induced acute liver injury in rats by syngeneic hepatocyte transplantation in spleen and peritoneal cavity |
| Q28346177 | Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine |
| Q90225107 | Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope? |
| Q37676601 | Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells |
| Q39828250 | Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging |
| Q37398418 | Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation |
| Q26741086 | Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks |
| Q26863145 | New insights in bilirubin metabolism and their clinical implications |
| Q68899761 | New method of hepatocyte transplantation and extracorporeal liver support |
| Q45882230 | Non-viral ex vivo hepatic gene transfer by in situ lipofection of liver and intraperitoneal transplantation of hepatocytes |
| Q39080593 | Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene |
| Q41558552 | Observations on rat spleen reticulum during the development of syngeneic hepatocellular implants |
| Q48283301 | Orthotopic liver transplantation for type I Crigler-Najjar syndrome |
| Q41328698 | Percutaneous transcatheter liver cell transplantation: an emerging modality and its clinical implications |
| Q45882192 | Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation |
| Q35018050 | Principles of hepatocyte repopulation |
| Q39521779 | Prospects for hepatocyte transplantation |
| Q35621337 | Quantitative evaluation of long-term liver repopulation and the reconstitution of bile ductules after hepatocellular transplantation |
| Q73161962 | Recombinant human hepatocyte growth factor facilitates biliary transport after hepatocyte transplantation in Eisai hyperbilirubinemic rats |
| Q68631151 | Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes |
| Q77716519 | Restoration of serum albumin levels in nagase analbuminemic rats by hepatocyte transplantation |
| Q34334381 | Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions |
| Q36395131 | Rodent models of alcoholic liver disease: of mice and men. |
| Q36744280 | Stem cell therapy for inherited metabolic disorders of the liver |
| Q35087066 | Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease |
| Q30381822 | Stem cells and the liver: clinical applications in transplantation. |
| Q36954413 | Stem cells in liver regeneration and therapy. |
| Q37402012 | Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats |
| Q59064606 | Targeting of drugs |
| Q35129278 | The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. |
| Q71259523 | The liver in Crigler-Najjar syndrome, protoporphyria, and other metabolic disorders |
| Q39642425 | Therapeutic amelioration of jaundice: old and new strategies |
| Q37760081 | Therapeutic liver repopulation for phenylketonuria |
| Q51728566 | Tissue engineering of the gastrointestinal tract for surgical replacement: a nutrition tool of the future? |
| Q28370692 | Transplantation of fetal liver tissue suspension into the spleens of adult syngenic rats: effects of various mitogens and cytotoxins on cytochrome P450 (P450) isoforms expression and on P450 mediated monooxygenase functions |
| Q73438228 | Transplantation of human hepatocytes |
| Q39567921 | Transplantation of isolated hepatocytes. A review of current ideas |
| Q81458559 | Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia |
| Q39613570 | Twenty-five years of progress in bilirubin metabolism (1952-77) |
| Q81297143 | [Minimally invasive substitute tissue in head and neck surgery] |
Search more.